gene therapy

ATMOSPHERE

Aug 24 2021

A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE)

Teaming Up for Gene Therapy

Aug 22 2021

*This article originally appeared in the McPherson Eye Research Institute Summer 2021 InSights Newsletter Millions of Americans currently battle inherited visual disorders, armed with very few therapeutic options. Recent advances in genome editing, which many believe…

Jan 22 2021

EDUCATION FOR CLINICAL PROFESSIONALS Residents and faculty present and discuss various case studies with the goal of improving clinical care practice. Held weekly throughout the year, grand rounds offers continuing medical education credit for ophthalmologists…

Can precision medicine treat childhood blindness?

Jan 25 2019

Using stem cells, gene therapy to correct errors in retinal cells A research team at the University of Wisconsin School of Medicine and Public Health has shown that two novel approaches to treating an inherited…

It’s a Go – The Clinical Trials Unit Embarks on the First Human Gene Therapy Trial in DOVS History

Mar 13 2018

The University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences (DOVS) has formally been announced as a partner site for Nightstar Therapeutics’ STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia. This is the first…

EDUCATION FOR CLINICAL PROFESSIONALS

Residents and faculty present and discuss various case studies with the goal of improving clinical care practice. Held weekly throughout the year, grand rounds offers continuing medical education credit for ophthalmologists and continuing education credit for optometrists.

PRESENTING THIS WEEK:

Curtis Brandt, PhD, FARVO, vice chair of research
“The Role of Innate and Intrinsic Resistance Factors in Viral Vector-mediated Ocular Gene Delivery”

JOIN WEBEX MEETING

MEETING NUMBER/ACCESS CODE: 120 085 8441

PASSWORD: DOVS (3687 from phones)

JOIN BY PHONE:

+1-415-655-0001 US Toll

STATEMENT OF ACCREDITATION
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME),the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENT
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The University of Wisconsin-Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA) authorizes this program for .1 CEUs or 1.0 hours.